Packaging & Label Design for Brands in Latvia

Latvia's EU membership and Baltic Sea trade position make Riga-based food and pharmaceutical brands natural exporters to Nordic and German markets; Russia and CIS export has been substantially curtailed since 2022 due to trade sanctions and Latvia's own import bans on Russian and Belarusian agricultural products. Grindeks, Latvia's largest pharmaceutical manufacturer (and originator of meldonium/Mildronate), has historically derived the majority of its revenues from Russia and other CIS countries, a market access risk that remains unresolved as of 2025–26, with the Latvian government vowing to cut trade with Russia while carving out a pharmaceutical sector exemption. New pharmaceutical packaging regulations came into force on 20 March 2024, expanding the circumstances in which marketing authorisation holders may distribute medicines in Latvia using foreign-language packaging without a separate ZVA permit.